by adminInside the Revival: Ibogaine Isn’t a Pill with Tom Feegel
S1E4: Ibogaine Isn’t a Pill: Building a Hospital-Grade Psychedelic ‘Reset’ at Beond. Host Jim Tate speaks with Tom Feegel, CEO & Co-Founder of Beond Ibogaine, about what it means to deliver ibogaine in a medically monitored setting.
Inside the Revival: From Lab Bench to Maloka with Melissa Stangl
S1E3: Melissa Stangl on Soltara’s Shipibo-Guided Ayahuasca Model, Safety Screening, and Integration That Actually Sticks. In this timely conversation, host Jim Tate engages Melissa Stangl, Founding Partner & Chief Operating Officer (COO), Soltara Healing Center, about her unlikely pivot from biomedical engineering and cancer research into the operational “backbone” of plant medicine work. Melissa walks through Soltara’s decision to focus on ayahuasca in the Shipibo tradition, why Costa Rica became the home base, and how the retreat arc is designed – from intake, medical/therapy screening, and preparation to post-retreat integration support. Along the way, we unpack practical realities: medication contraindications (especially SSRIs + MAOI risk), why some guests report ‘nothing happened,’ (a failure to hit escape vel;ocity – of you will) individualized dosing, and why Soltara treats integration as a year-long continuum – not an afterthought.
Inside The Revival: Mushrooms, Methods, and Meaning with Charles Lazarus
S1E2: Mushrooms, Methods, and Meaning: Inside Jamaica’s Legal Psilocybin Supply with Rose Hill’s Charles Lazarus
Host Jim Tate and Charles Lazarus, from Rose Hill discuss legal context, cultivation science, clinical collaboration, whole mushroom vs. synthetics, veteran healing programs, microdosing and mindset, along with ethical entrepreneurship.
